Hypertrophic Regression With N-Acetylcysteine in HCM
Status:
Completed
Trial end date:
2016-12-31
Target enrollment:
Participant gender:
Summary
The purpose of the sudy is to conduct a small study to gather the preliminary data for future
lage scale clinical studies that will be designed test the potential beneficial effect of
over-the counter study anti-oxidant drug called N-acetylcysteine (NAC) in patients with a
heart muscle condition called Hypertrophic Cardiomyopathy (HCM). The present study is a pilot
feasibility study, the investigators want to find out whether the investigators can recruit
and retain patients with HCM in the study and whether these patients can tolerate this drug
and can stay on one year. Likewise, the investigators want to find out any potential side
effects that this drug might have and estimate whether it has any beneficial effects.
Phase:
Phase 1
Details
Lead Sponsor:
The University of Texas Health Science Center, Houston